Doxycycline is the Likely Culprit for This Photosensitivity Reaction
Yes, doxycycline can definitely cause a photosensitivity rash with raised bumps on sun-exposed areas like the forearms, while lisinopril is not a known photosensitizing agent. The raised lesions on sunburned forearms are consistent with doxycycline-induced phototoxicity 1.
Why Doxycycline is Responsible
Doxycycline causes phototoxic reactions that manifest as exaggerated sunburn-like symptoms including:
- Burning and erythema (redness)
- Raised lesions on sun-exposed skin
- Symptoms ranging from mild burning to large-area photodermatitis 2
The FDA label explicitly warns that "photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines" and advises discontinuation at the first evidence of skin erythema 1. The mechanism involves primarily UVA1 spectrum (340-400 nm), meaning standard sunscreens may not provide adequate protection 2.
Clinical Evidence on Frequency
The incidence varies but is well-documented:
- In a large cohort of 858 patients, photosensitivity occurred in 1.9% (95% CI 1.1-3.0%) 3
- Reactions were more common in women (2.7% vs 0.8% in men) 3
- Peak occurrence was June through October, highest in July 3
- Most affected patients (13/16) did not adhere to sun avoidance recommendations 3
Recent 2026 research confirms enalapril (an ACE inhibitor like lisinopril) can cause photosensitivity, but the evidence is far weaker and less clinically significant than for doxycycline 4.
Why Lisinopril is Unlikely
The FDA label for lisinopril lists extensive warnings about angioedema, hypotension, and renal impairment but makes no mention of photosensitivity or phototoxic reactions 5. While one 2026 study showed enalapril (another ACE inhibitor) caused increased erythema with UV exposure 4, this was experimental research with controlled UV doses—not real-world clinical photosensitivity like what doxycycline causes.
Immediate Management
Discontinue doxycycline immediately 1. The FDA label states treatment should be stopped "at the first evidence of skin erythema" 1.
Supportive Care:
- Avoid further sun exposure completely
- Use broad-spectrum sunscreen covering UVA1 range (340-400 nm) if sun exposure is unavoidable 2
- Topical corticosteroids for symptomatic relief
- Oral antihistamines if pruritus is present
Expected Course:
All documented cases showed complete resolution with no long-term sequelae after drug discontinuation 3. The raised bumps should resolve within days to weeks.
Critical Pitfall to Avoid
The most common mistake is inadequate sun protection counseling. In the largest study, 81% of patients who developed photosensitivity had not properly avoided sun exposure 3. If doxycycline must be continued for any reason, patients need explicit instructions about:
- Complete sun avoidance during peak hours (10 AM - 4 PM)
- Protective clothing covering all exposed skin
- Broad-spectrum UVA1-blocking sunscreen (not just UVB protection)
Alternative Antibiotics
If the patient requires continued antibiotic therapy, consider switching to a non-tetracycline antibiotic depending on the indication. Among tetracyclines, sarecycline and minocycline appear to have lower phototoxicity risk than doxycycline 6, though this should not be the first choice if a non-tetracycline option exists.